EUVIMEDEUVIMED entdecken
Crossref

Development and Pilot Clinical Study of a Novel FAP-Targeted PET Tracer for PET Imaging of Tumors

Keyin Chen, Rongqin Zhang, Xiaojun Zhang iD, Weijiang Liao, Yongqiang Zhang, Yi Liu, Jiawen Huang iD, Zhanwen Zhang, Ganghua Tang iD

Analytical Chemistry · 12.05.2026 · 98 (18) · 13386-13396

DOI: 10.1021/acs.analchem.5c07388 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 30.04.2026. Verfasst von Keyin Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory Project of Guangdong Provincial Department of Education for Ordinary Universities and GDMPA Key Laboratory for Quality Control and Eva…. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Serine Endopeptidases, Gelatinases, Membrane Proteins. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, Department of Education of Guangdong Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In recent years, fibroblast activation protein (FAP) has become a promising target, with FAPI tracers proving effective for tumor diagnosis. This study designs a novel FAPI tracer ([18F]AlF-AA-FAPT) for FAP imaging, aiming to enhance the pharmacokinetic properties of existing tracers, further enhancing tumor uptake, and reducing background uptake in nontarget organs. The radiochemical synthesis of [18F]AlF-AA-FAPT is simple, and the product has high purity, excellent in vitro and in vivo stability, hydrophilicity, and targeting affinity. Micro-PET/CT imaging demonstrates that [18F]AlF-AA-FAPT has higher tumor-specific uptake, lower tissue accumulation, and faster renal clearance than existing tracers [18F]AlF-FAPI-42 and [18F]AlF-FAPT. Our pilot clinical study directly compares [18F]AlF-AA-FAPT with [18F]FDG in six cancer patients, revealing that the novel tracer exhibits superior pharmacokinetic properties and provides enhanced imaging efficacy for both primary and metastatic lesions across certain cancer types. These results suggest that [18F]AlF-AA-FAPT demonstrates excellent target-to-background ratio and improves pharmacokinetic properties, making it an effective alternative to current FAPI tracers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron-Emission TomographySerine EndopeptidasesGelatinasesMembrane ProteinsRadiopharmaceuticalsNeoplasmsPositron Emission Tomography Computed TomographyHumansPilot ProjectsAnimalsFibroblast Activation Protein AlphaEndopeptidasesMiceFluorine Radioisotopes

Substanzen

Fibroblast Activation Protein AlphaEndopeptidasesSerine EndopeptidasesGelatinasesMembrane ProteinsRadiopharmaceuticalsFluorine Radioisotopes

Autor:innen und Institutionen

  • Key Laboratory Project of Guangdong Provincial Department of Education for Ordinary Universities and GDMPA Key Laboratory for Quality Control and Evaluation of Radiopharmaceuticals, Department of Nuclear Medicine, Nanfa…
  • School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, Guangdong Province 510515, China.
  • Department of Nuclear Medicine, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510655, China.
  • Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510655, China.

ORCID-Profile: Xiaojun Zhang, Jiawen Huang, Ganghua Tang

Förderung

  • Basic and Applied Basic Research Foundation of Guangdong Province
  • Department of Education of Guangdong Province
  • National Natural Science Foundation of China
  • Nanfang Hospital Talent Introduction Foundation of Southern Medical University
  • Medical Products Administration of Guangdong Province
  • Guangzhou Science and Technology Plan Foundation

Zitieren

APA

Chen, K., Zhang, R., Zhang, X., Liao, W., Zhang, Y., Liu, Y., Huang, J., Zhang, Z., & Tang, G. (2026). Development and Pilot Clinical Study of a Novel FAP-Targeted PET Tracer for PET Imaging of Tumors. Analytical Chemistry, 98(18), 13386-13396. https://doi.org/10.1021/acs.analchem.5c07388

Vancouver

Chen K, Zhang R, Zhang X, Liao W, Zhang Y, Liu Y, et al. Development and Pilot Clinical Study of a Novel FAP-Targeted PET Tracer for PET Imaging of Tumors. Analytical Chemistry. 2026;98(18):13386-13396. doi:10.1021/acs.analchem.5c07388

BibTeX
@article{Chen2026,
  author = {Chen, Keyin and Zhang, Rongqin and Zhang, Xiaojun and Liao, Weijiang and Zhang, Yongqiang and Liu, Yi and Huang, Jiawen and Zhang, Zhanwen and Tang, Ganghua},
  title = {Development and Pilot Clinical Study of a Novel FAP-Targeted PET Tracer for PET Imaging of Tumors},
  journal = {Analytical Chemistry},
  year = {2026},
  volume = {98},
  number = {18},
  pages = {13386--13396},
  doi = {10.1021/acs.analchem.5c07388}
}
Kostenlos starten →